Immunogenicity and Safety of High-Dose Trivalent Inactivated Influenza Vaccine Compared to Standard-Dose Vaccine in Children and Young Adults with Cancer or HIV Infection

BACKGROUND: Approaches to improve the immune response of immunocompromised patients to influenza vaccination are needed. METHODS: Children and young adults (3–21 years) with cancer or HIV infection were randomized to receive 2 doses of high-dose (HD) trivalent influenza vaccine (TIV) or of standard-...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Vaccine
Hlavní autoři: Hakim, Hana, Allison, Kim J., Van de Velde, Lee-Ann, Tang, Li, Sun, Yilun, Flynn, Patricia M., McCullers, Jonathan A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4899146/
https://ncbi.nlm.nih.gov/pubmed/27129426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2016.04.053
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky